{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:40:23Z","timestamp":1790854823611,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":4664,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.3945\/jn.109.115006","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T04:14:37Z","timestamp":1269490477000},"page":"962-968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in Rats"],"prefix":"10.1016","volume":"140","author":[{"given":"Peter","family":"Wojciechowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijel","family":"Juric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier Lieben","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijo Joseph","family":"Thandapilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Netticadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/jn.109.115006_bib1","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.biocel.2008.03.002","article-title":"Heart failure: targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment","volume":"40","author":"Latronico","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.3945\/jn.109.115006_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nature06798","article-title":"Tackling heart failure in the twenty-first century","volume":"451","author":"Mudd","year":"2008","journal-title":"Nature"},{"key":"10.3945\/jn.109.115006_bib3","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart: a new therapeutic target?","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"key":"10.3945\/jn.109.115006_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"10.3945\/jn.109.115006_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","article-title":"Controversies in ventricular remodelling","volume":"367","author":"Opie","year":"2006","journal-title":"Lancet"},{"key":"10.3945\/jn.109.115006_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cardiores.2004.04.031","article-title":"Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence","volume":"63","author":"Selvetella","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.3945\/jn.109.115006_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejheart.2008.01.002","article-title":"Overview of emerging pharmacologic agents for acute heart failure syndromes","volume":"10","author":"De Luca","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.3945\/jn.109.115006_bib8","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1097\/01.CCM.0000296810.74724.8D","article-title":"New pharmacologic therapies for acute heart failure","volume":"36","author":"Tavares","year":"2008","journal-title":"Crit Care Med"},{"key":"10.3945\/jn.109.115006_bib9","first-page":"33","article-title":"Emerging drug therapies for the management of acute decompensated heart failure","volume":"100","author":"Tunuguntla","year":"2007","journal-title":"Tenn Med"},{"key":"10.3945\/jn.109.115006_bib10","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1016\/j.amjcard.2008.03.007","article-title":"Nutritional and anti-inflammatory interventions in chronic heart failure","volume":"101","author":"Kalantar-Zadeh","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.3945\/jn.109.115006_bib11","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1093\/ajcn\/83.2.421S","article-title":"Nutritional mechanisms that influence cardiovascular disease","volume":"83","author":"De Caterina","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/jn.109.115006_bib12","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1208\/ps050325","article-title":"Nutraceutical: definition and introduction","volume":"5","author":"Kalra","year":"2003","journal-title":"AAPS PharmSci"},{"key":"10.3945\/jn.109.115006_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/138920106775789647","article-title":"Nutraceuticals: an emerging era in the treatment and prevention of cardiovascular diseases","volume":"7","author":"Ramaa","year":"2006","journal-title":"Curr Pharm Biotechnol"},{"key":"10.3945\/jn.109.115006_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/157489007780832560","article-title":"Resveratrol: a therapeutic promise for cardiovascular diseases","volume":"2","author":"Das","year":"2007","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"10.3945\/jn.109.115006_bib15","doi-asserted-by":"crossref","first-page":"H2138","DOI":"10.1152\/ajpheart.00852.2006","article-title":"Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol","volume":"292","author":"Juric","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.3945\/jn.109.115006_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.yjmcc.2005.02.012","article-title":"A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload","volume":"38","author":"Cantor","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"10.3945\/jn.109.115006_bib17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements","volume":"58","author":"Sahn","year":"1978","journal-title":"Circulation"},{"key":"10.3945\/jn.109.115006_bib18","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/HYPERTENSIONAHA.107.100545","article-title":"Pregnancy reverses hypertensive remodeling of cerebral arteries","volume":"51","author":"Cipolla","year":"2008","journal-title":"Hypertension"},{"key":"10.3945\/jn.109.115006_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.freeradbiomed.2004.10.020","article-title":"Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways","volume":"38","author":"Li","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.3945\/jn.109.115006_bib20","doi-asserted-by":"crossref","first-page":"24194","DOI":"10.1074\/jbc.M802869200","article-title":"Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt","volume":"283","author":"Chan","year":"2008","journal-title":"J Biol Chem"},{"key":"10.3945\/jn.109.115006_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ajh.2009.228","article-title":"Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure","volume":"23","author":"Thandapilly","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.3945\/jn.109.115006_bib22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1292\/jvms.70.1231","article-title":"Effects of beta-blocker on left ventricular remodeling in rats with volume overload cardiac failure","volume":"70","author":"Kobayashi","year":"2008","journal-title":"J Vet Med Sci"},{"key":"10.3945\/jn.109.115006_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1254\/jjp.86.79","article-title":"Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload","volume":"86","author":"Tokioka-Akagi","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"10.3945\/jn.109.115006_bib24","first-page":"H2345","article-title":"Regression of cardiac hypertrophy after closing an aortocaval fistula in rats","volume":"268","author":"Gerdes","year":"1995","journal-title":"Am J Physiol"},{"key":"10.3945\/jn.109.115006_bib25","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0891-5849(02)01430-2","article-title":"Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia\/reperfusion, platelet-activating factor, or oxidants","volume":"34","author":"Shigematsu","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.3945\/jn.109.115006_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/10715760802673008","article-title":"Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage","volume":"43","author":"Tatlidede","year":"2009","journal-title":"Free Radic Res"},{"key":"10.3945\/jn.109.115006_bib27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/hrt.2005.068270","article-title":"Oxidative stress and redox signalling in cardiac hypertrophy and heart failure","volume":"93","author":"Seddon","year":"2007","journal-title":"Heart"},{"key":"10.3945\/jn.109.115006_bib28","doi-asserted-by":"crossref","first-page":"H620","DOI":"10.1152\/ajpheart.01236.2006","article-title":"Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload","volume":"293","author":"Buys","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.3945\/jn.109.115006_bib29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.bjp.0707622","article-title":"Knockout of beta (1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis","volume":"153","author":"Kiriazis","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.3945\/jn.109.115006_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/hc0202.102015","article-title":"Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure","volume":"105","author":"Gealekman","year":"2002","journal-title":"Circulation"}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316622070560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316622070560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/jn\/article-pdf\/140\/5\/962\/23951056\/962.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T23:10:48Z","timestamp":1686697848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022316622070560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0022316622070560"],"URL":"https:\/\/doi.org\/10.3945\/jn.109.115006","relation":{},"ISSN":["0022-3166"],"issn-type":[{"value":"0022-3166","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/jn.109.115006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}